52 related articles for article (PubMed ID: 34196992)
21. CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients.
Ma J; Yang L; Feng H; Zheng L; Meng H; Li X
J Clin Lab Anal; 2021 Aug; 35(8):e23793. PubMed ID: 34196992
[TBL] [Abstract][Full Text] [Related]
22. Chaperonin-containing tailless complex polypeptide 1 subunit 6A links with aggravating tumor features and disease-free survival in surgical gastric cancer patients: A long-term follow-up study.
He T; Yu D; Wang Z; Guo C; Chang Y; Wang D
Clin Res Hepatol Gastroenterol; 2022; 46(7):101913. PubMed ID: 35346891
[TBL] [Abstract][Full Text] [Related]
23. Chaperonin-containing tailless complex polypeptide 1 subunit 6A correlates with increased World Health Organization grade, less isocitrate dehydrogenase mutation, and deteriorative survival of astrocytoma patients.
Hu Y; Fu P; Zhao H; Zhang F; Jiang X; Zhao W; Lv P
J Clin Lab Anal; 2021 Sep; 35(9):e23917. PubMed ID: 34312925
[TBL] [Abstract][Full Text] [Related]
24. CCT6A expression in hepatocellular carcinoma and its correlation with clinical characteristics, liver function indexes, tumor markers and prognosis.
Cai Y; Wu D; Zhan L
Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101796. PubMed ID: 34500119
[TBL] [Abstract][Full Text] [Related]
25. CCT6A dysregulation in surgical prostate cancer patients: association with disease features, treatment information, and prognosis.
Peng S; Yu J; Wang Y
Ir J Med Sci; 2024 Feb; 193(1):85-93. PubMed ID: 37523068
[TBL] [Abstract][Full Text] [Related]
26. CCT6A, a novel prognostic biomarker for Ewing sarcoma.
Jiang J; Liu C; Xu G; Liang T; Yu C; Liao S; Zhang Z; Lu Z; Wang Z; Chen J; Chen T; Li H; Zhan X
Medicine (Baltimore); 2021 Jan; 100(4):e24484. PubMed ID: 33530265
[TBL] [Abstract][Full Text] [Related]
27. Cervical Cancer: Emerging Immune Landscape and Treatment.
Guo L; Hua K
Onco Targets Ther; 2020; 13():8037-8047. PubMed ID: 32884290
[TBL] [Abstract][Full Text] [Related]
28. Chaperonin containing t-complex polypeptide 1 subunit 6A correlates with lymph node metastasis, abnormal carcinoembryonic antigen and poor survival profiles in non-small cell lung carcinoma.
Zhang T; Shi W; Tian K; Kong Y
World J Surg Oncol; 2020 Jul; 18(1):156. PubMed ID: 32631353
[TBL] [Abstract][Full Text] [Related]
29. Cervical Cancer: 2018 Revised International Federation of Gynecology and Obstetrics Staging System and the Role of Imaging.
Saleh M; Virarkar M; Javadi S; Elsherif SB; de Castro Faria S; Bhosale P
AJR Am J Roentgenol; 2020 May; 214(5):1182-1195. PubMed ID: 32182097
[No Abstract] [Full Text] [Related]
30. Pterostilbene Suppresses both Cancer Cells and Cancer Stem-Like Cells in Cervical Cancer with Superior Bioavailability to Resveratrol.
Shin HJ; Han JM; Choi YS; Jung HJ
Molecules; 2020 Jan; 25(1):. PubMed ID: 31935877
[TBL] [Abstract][Full Text] [Related]
31. Overexpressing CCT6A Contributes To Cancer Cell Growth By Affecting The G1-To-S Phase Transition And Predicts A Negative Prognosis In Hepatocellular Carcinoma.
Zeng G; Wang J; Huang Y; Lian Y; Chen D; Wei H; Lin C; Huang Y
Onco Targets Ther; 2019; 12():10427-10439. PubMed ID: 31819524
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus vaccine against cervical cancer: Opportunity and challenge.
Wang R; Pan W; Jin L; Huang W; Li Y; Wu D; Gao C; Ma D; Liao S
Cancer Lett; 2020 Feb; 471():88-102. PubMed ID: 31812696
[TBL] [Abstract][Full Text] [Related]
33. Identification of Key Genes and Pathways in Cervical Cancer by Bioinformatics Analysis.
Wu X; Peng L; Zhang Y; Chen S; Lei Q; Li G; Zhang C
Int J Med Sci; 2019; 16(6):800-812. PubMed ID: 31337953
[TBL] [Abstract][Full Text] [Related]
34. Bioinformatics analysis of the prognostic value of CCT6A and associated signalling pathways in breast cancer.
Huang K; Zeng Y; Xie Y; Huang L; Wu Y
Mol Med Rep; 2019 May; 19(5):4344-4352. PubMed ID: 30942452
[TBL] [Abstract][Full Text] [Related]
35. Cervical cancer.
Cohen PA; Jhingran A; Oaknin A; Denny L
Lancet; 2019 Jan; 393(10167):169-182. PubMed ID: 30638582
[TBL] [Abstract][Full Text] [Related]
36. EIF3B correlates with advanced disease stages and poor prognosis, and it promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
Tian Y; Zhao K; Yuan L; Li J; Feng S; Feng Y; Fang Z; Li H; Deng R
Cancer Biomark; 2018; 23(2):291-300. PubMed ID: 30198870
[TBL] [Abstract][Full Text] [Related]
37. Tumor-infiltrating CD45RO
Hu Z; Gu X; Zhong R; Zhong H
J Thorac Dis; 2018 Apr; 10(4):2089-2099. PubMed ID: 29850112
[TBL] [Abstract][Full Text] [Related]
38. CCT6A suppresses SMAD2 and promotes prometastatic TGF-β signaling.
Ying Z; Tian H; Li Y; Lian R; Li W; Wu S; Zhang HZ; Wu J; Liu L; Song J; Guan H; Cai J; Zhu X; Li J; Li M
J Clin Invest; 2017 May; 127(5):1725-1740. PubMed ID: 28375158
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology and Early Detection of Cervical Cancer.
Hillemanns P; Soergel P; Hertel H; Jentschke M
Oncol Res Treat; 2016; 39(9):501-6. PubMed ID: 27614953
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
